Suppr超能文献

婴儿腹膜透析:意大利儿科慢性透析登记处的经验。

Peritoneal dialysis in infants: the experience of the Italian Registry of Paediatric Chronic Dialysis.

机构信息

Paediatric Nephrology, Dialysis and Transplantation Unit, Department of Paediatrics, University of Padua, Padova, Italy.

出版信息

Nephrol Dial Transplant. 2012 Jan;27(1):388-95. doi: 10.1093/ndt/gfr322. Epub 2011 Jun 9.

Abstract

BACKGROUND

Although chronic peritoneal dialysis (CPD) is considered the replacement therapy of choice for infants with end-stage renal failure, many questions persist about treatment risks and outcomes.

METHODS

We present data on 84 infants who started CPD at <1 year of age; these patients represent 12% of the total population of the Italian Registry of Paediatric Chronic Dialysis. We analysed patient records from all children consecutively treated with CPD between 1995 and 2007 in Italy. Growth data analysis was performed only in infants with complete auxological parameters at 0, 6 and 12 months of follow-up.

RESULTS

Median age at the start of CPD was 6.9 months, weight was 6.1 kg and length 63.6 cm. In one-half of the study population diagnosis leading to renal failure was congenital nephrouropathy. Twenty-eight per cent of the children had at least one pre-existing comorbidity. The mean height standard deviation score was -1.65 at the start of CPD, -1.82 after 12 months and -1.53 after 24 months. Catch-up growth was documented in 50% of patients during dialysis. A positive correlation was observed between longitudinal growth and both exchange volume (R(2) = 0.36) and dialysis session length (R(2) = 0.35), while a negative association was found with the number of peritonitis cases (P = 0.003). Peritonitis incidence was 1:20.7 episode:CPD-months (1:28.3 in the older children from the same registry) and was significantly higher in children with oligoanuria (1:15.5 episode:CPD-months) compared to infants with residual renal function (1:37.4 episode:CPD-months). Catheter survival rate was 70% at 12 months and 51% at 24 months. Catheter-related complications were similar in infants and older children (1:20.5 versus 1:19.8 episode:CPD-months), while clinical complications were more frequent in children under 1 year of age (1:18.3 versus 1:25.2 episode:CPD-months; P < 0.05). During the follow-up period, 33 patients were transplanted (39.3%), 18 were shifted to haemodialysis (21.4%) and 8 died (9.5%). The mortality rate was 4-fold greater than in older children (2.3%).

CONCLUSIONS

Our data confirm that infants on CPD represent a high-risk group; however, our experience demonstrated that growth was acceptable and a large portion was successfully transplanted. Increased efforts should be aimed at optimizing dialysis efficiency and preventing peritonitis. The higher mortality rate in infants was largely caused by comorbidities.

摘要

背景

尽管慢性腹膜透析(CPD)被认为是终末期肾衰竭婴儿的首选替代疗法,但关于治疗风险和结果仍存在许多问题。

方法

我们介绍了 84 名在<1 岁时开始接受 CPD 治疗的婴儿的数据;这些患者占意大利儿科慢性透析登记处总人数的 12%。我们分析了 1995 年至 2007 年期间在意大利连续接受 CPD 治疗的所有儿童的病历。仅对随访 0、6 和 12 个月时具有完整生长参数的婴儿进行生长数据分析。

结果

CPD 起始时的中位年龄为 6.9 个月,体重为 6.1kg,身高为 63.6cm。研究人群的一半有先天性肾输尿管畸形导致的肾脏衰竭。28%的儿童至少有一种合并症。CPD 起始时,患儿的平均身高标准差评分为-1.65,12 个月后为-1.82,24 个月后为-1.53。50%的患儿在透析期间出现追赶生长。纵向生长与交换量(R2=0.36)和透析疗程(R2=0.35)呈正相关,而与腹膜炎病例数呈负相关(P=0.003)。腹膜炎的发病率为每 20.7 个疗程:CPD-月(同一登记处的大龄儿童为每 28.3 个疗程),在少尿的儿童中(每 15.5 个疗程:CPD-月)明显高于有残余肾功能的婴儿(每 37.4 个疗程:CPD-月)。12 个月时导管的存活率为 70%,24 个月时为 51%。婴儿和大龄儿童的导管相关并发症相似(每 20.5 个疗程:CPD-月比每 19.8 个疗程:CPD-月),而 1 岁以下儿童的临床并发症更常见(每 18.3 个疗程:CPD-月比每 25.2 个疗程:CPD-月;P<0.05)。在随访期间,33 名患者接受了移植(39.3%),18 名患者转为血液透析(21.4%),8 名患者死亡(9.5%)。死亡率是大龄儿童的 4 倍(2.3%)。

结论

我们的数据证实,CPD 患儿是一个高危群体;然而,我们的经验表明,生长是可以接受的,且大部分患儿成功接受了移植。应加大力度提高透析效率,预防腹膜炎。婴儿死亡率较高主要是由于合并症。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验